Legal & General Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Legal & General Group’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,959	Closed	-$25K	–	3319
2016 Q4	$25K	Buy	4,959 +1,330	+37%	+$6.81K	﹤0.01%	3085
2016 Q3	$17K	Hold	3,629	–	–	﹤0.01%	2828
2016 Q2	$18K	Hold	3,629	–	–	﹤0.01%	2860
2016 Q1	$20K	Hold	3,629	–	–	﹤0.01%	2672
2015 Q4	$38K	Hold	3,629	–	–	﹤0.01%	2575
2015 Q3	$66K	Hold	3,629	–	–	﹤0.01%	2302
2015 Q2	$69K	Hold	3,629	–	–	﹤0.01%	2394
2015 Q1	$64K	Hold	3,629	–	–	﹤0.01%	2365
2014 Q4	$58K	Hold	3,629	–	–	﹤0.01%	2348
2014 Q3	$46K	Buy	+3,629	New	+$51.8K	﹤0.01%	2443

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Legal & General Group's OSIR Position: Q1 2017 in Review

Legal & General Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 4,959 shares — an estimated $25K sold.

Legal & General Group first reported a position in OSIR in Q3 2014 and held it in 10 quarters. The position peaked at $69K in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

Legal & General Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Legal & General Group sold 4,959 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $25K.
Legal & General Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2014 and held it in 10 quarters.
Legal & General Group's Osiris Therapeutics, Inc. Common Stock position peaked at $69K in Q2 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Legal & General Group's 13F filing for Q1 2017, filed 12 May 2017.